Withaferin a synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Fong, Miranda Y ^a   Jin, Shunying ^a   Rane, Madhavi ^a   Singh, Raj K ^b   Gupta, Ramesh ^a,c   Kakar, Sham S ^a,c  

^a University of Louisville School of Medicine   (United States)

^b Vivo Biosciences Inc   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DOXORUBICIN; REACTIVE OXYGEN METABOLITE; WITHAFERIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL STRESS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MONOTHERAPY; MOUSE; NONHUMAN; OVARY CANCER; OXIDATION; PROTEIN CLEAVAGE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CELL LINE, TUMOR; DNA DAMAGE; DOXORUBICIN; DRUG SYNERGISM; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; OVARIAN NEOPLASMS; REACTIVE OXYGEN SPECIES; WITHANOLIDES;

ANIMALIA;

EID: 84864423853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042265     Document Type: Article

References (53)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Pfisterer J, Ledermann JA, (2006) Management of platinum-sensitive recurrent ovarian cancer. Semin Oncol 33: S12-16.
3. Matsuo K, Lin YG, Roman LD, Sood AK, (2010) Overcoming platinum resistance in ovarian carcinoma. Expert Opin Investig Drugs 19: 1339-1354.
4. Singal PK, Li T, Kumar D, Danelisen I, Iliskovic N, (2000) Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 207: 77-86.
5. Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, et al. (2009) Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16: 3267-3285.
6. Campos SM, Penson RT, Mays AR, Berkowitz RS, et al. (2001) The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer. Gyn Oncol 81: 206-212.
7. Das A, Durrant D, Mitchell C, Mayton E, Hoke NN, et al. (2010) Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction. Proc Natl Acad Sci U S A 107: 18202-18207.
8. Dayton A, Selvendiran K, Meduru S, Khan M, Kuppusamy M, et al. (2011) Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function compound, HO-3867. J Pharmacol Exp Ther 339: 350-357.
9. Stan SD, Hahm ER, Warin R, Singh SV, (2008) Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res 68: 7661-7669.
10. Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, et al. (2004) Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7: 115-122.
11. Oh JH, Kwon TK, (2009) Withaferin A inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules by inactivation of Akt and NF-kappaB in human pulmonary epithelial cells. Int Immunopharmacol 9: 614-619.
12. Mayola E, Gallerne C, Esposti DD, Martel C, Pervaiz S, et al. (2011) Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis 16: 1014-1027.
13. Koduru S, Kumar R, Srinivasan S, Evers MB, (2010) Damodaran C Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol Cancer Ther 9: 202-210.
14. Srinivasan S, Ranga RS, Burikhanov R, Han SS, Chendil D, (2007) Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res 67: 246-253.
15. Yu Y, Hamza A, Zhang T, Gu M, Zou P, et al. (2010) Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol 79: 542-551.
16. Stan SD, Zeng Y, Singh SV, (2008) Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr Cancer 60 (Suppl 1): 51-60.
17. Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, et al. (2007) Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 12: 2115-2133.
18. Lee TJ, Um HJ, Min do S, Park JW, Choi KS, et al. (2009) Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic Biol Med 46: 1639-1649.
19. Munagala R, Kausar H, Munjal C, Gupta RC, (2011) Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis 32: 1697-1705.
20. Kaur K, Widodo N, Nagpal A, Kaul SC, Wadhwa R, (2007) Sensitization of human cancer cells to anti-cancer drugs of leaf extract of Ashwagandha (Lash). Tiss Cult Res Commun 26: 193-199.
21. Eva A, Robbins KC, Andersen PR, Srinivasan A, Tronick SR, et al. (1982) Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature 295 (5845): 116-119.21.
22. Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, et al. (1987) Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47: 414-418.
23. Hamid T, Malik MT, Kakar SS, (2005) Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells. Mol Cancer 4: 3.
24. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immun Methods 281: 65-78.
25. Rane MJ, Song Y, Jin S, Barati MT, Wu R, et al. (2010) Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy. Am J Physiol Renal Physiol 298: F49-61.
26. Shah PP, Fong MY, Kakar SS (2011) PTTG induces EMT through integrin alpha(V)beta(3)-focal adhesion kinase signaling in lung cancer cells. Oncogene.
27. El-Naggar SM, Malik MT, Kakar SS, (2007) Small interfering RNA against PTTG: a novel therapy for ovarian cancer. Int J Oncol 31: 137-143.
28. El-Naggar SM, Malik MT, Martin A, Moore JP, Proctor M, et al. (2007) Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice. J Endocrinol 194: 179-191.
29. Gewirtz DA, (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727-741.
30. Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK, (2011) Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chem Biol Interact 190: 9-15.
31. Gaetani GF, Ferraris AM, Rolfo M, Mangerini R, Arena S, et al. (1996) Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood 87: 1595-1599.
32. McCord JM, Fridovich I, (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055.
33. Notte A, Leclere L, Michiels C, (2011) Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem Pharmacol 82: 427-434.
34. Cosse JP, Rommelaere G, Ninane N, Arnould T, Michiels C, (2010) BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathway. Biochem Pharmacol 80: 1160-1169.
35. Lee SB, Tong SY, Kim JJ, Um SJ, Park JS, (2007) Caspase-independent autophagic cytotoxicity in etoposide-treated CaSki cervical carcinoma cells. DNA Cell Biol 26: 713-720.
36. Lin CI, Whang EE, Donner DB, Du J, Lorch J, et al. (2010) Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer. Mol Cancer Res 8: 1217-1226.
37. Lambert LA, Qiao N, Hunt KK, Lambert DH, Mills GB, et al. (2008) Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68: 7966-7974.
38. Manov I, Pollak Y, Broneshter R, Iancu TC, (2011) Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib- the role of extracellular signal-regulated kinase counteraction. FEBS J 278: 3494-3507.
39. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, et al. (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21: 1367-1381.
40. Seales EC, Belousova R, Singh R, (2007) 3D tumorigenesis and angiogenesis assay models: predicting better functional and preclinical endpoints. Drug discovery + international. pp. 16-19.
41. Kudoh K, Takano M, Kouta H, Kikuchi R, Kita T, et al. (2011) Effects of bevacizumab and pegylated liposomal doxorubicin for the patients with recurrent or refractory ovarian cancers. Gynecol Oncol 122: 233-237.
42. Achari C, Reddy GV, Reddy TC, Reddanna P, (2011) Chebulagic Acid Synergizes the Cytotoxicity of Doxorubicin in Human Hepatocellular Carcinoma Through COX-2 Dependant Modulation of MDR-1. Med Chem 7: 432-442.
43. Tomuleasa C, Soritau O, Fischer-Fodor E, Pop T, Susman S, et al. (2011) Arsenic trioxide plus cisplatin/interferon alpha-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma. Hematol Oncol Stem Cell Ther 4: 60-66.
44. Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, et al. (2011) Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int J Cancer.
45. Ricci MS, Zong WX, (2006) Chemotherapeutic approaches for targeting cell death pathways. Oncologist 11: 342-357.
46. Hatchi E, Rodier G, Sardet C, Le Cam LO, (2011) E4F1 dysfunction results in autophagic cell death in myeloid leukemic cells. Autophagy 7: 1566-1567.
47. Donadelli M, Dando I, Zaniboni T, Costanzo C, Dalla Pozza E, et al. (2011) Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis 2: e152.
48. Lee YJ, Kim NY, Suh YA, Lee C, (2011) Involvement of ROS in Curcumin-induced Autophagic Cell Death. Korean J Physiol Pharmacol 15: 1-7.
49. Kuo CC, Liu TW, Chen LT, Shiah HS, Wu CM, et al. (2011) Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors. Free Radic Biol Med 51: 2195-2209.
50. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, et al. (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90: 1383-1435.
51. Mazure NM, Pouyssegur J, (2010) Hypoxia-induced autophagy: cell death or cell survival? Curr Opin Cell Biol 22: 177-180.
52. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, et al. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420.
53. Siegal GP, Wang MH, Rinehart CA, Kennedy JW, Goodly LJ, et al. (1993) Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells. Cancer Lett 69: 123-132.